IE
TMDI

Israel Englander’s Titan Medical Inc. Ordinary Shares TMDI Stock Holding History

Israel Englander’s Portfolio TMDI Stock Details TMDI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-129,667
Closed -$222K – 7451
2021
Q2 		$222K Buy
+129,667
New +$224K ﹤0.01% 5952

Other funds holding TMDI

MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
EL
Essex LLC Deer Park, Illinois $659M AUM 41.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CCG
Ceeto Capital Group Coral Gables, Florida $369M AUM 34.8% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
COF
Capital One Financial Mclean, Virginia $141M AUM 2.36% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return

Israel Englander's TMDI Position: Q3 2021 in Review

Israel Englander sold out of Titan Medical Inc. Ordinary Shares (TMDI) in Q3 2021, closing a stake of 129,667 shares — an estimated $222K sold.

Israel Englander first reported a position in TMDI in Q2 2021 and held it in 1 quarter. The position peaked at $222K in Q2 2021. 55 funds tracked by Wall St. Rank hold TMDI as of Q3 2021.

  • Israel Englander reported no remaining Titan Medical Inc. Ordinary Shares position as of Q3 2021 after selling out during the quarter.
  • Israel Englander sold 129,667 Titan Medical Inc. Ordinary Shares shares in Q3 2021, an estimated $222K.
  • Israel Englander first reported a position in Titan Medical Inc. Ordinary Shares in Q2 2021 and held it in 1 quarter.
  • Israel Englander's Titan Medical Inc. Ordinary Shares position peaked at $222K in Q2 2021.
  • 55 funds tracked by Wall St. Rank held Titan Medical Inc. Ordinary Shares as of Q3 2021.

Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.